Joachim Hombach

Next generation dengue vaccines: a review of candidates in preclinical development.

A. Barrett, J. Roehrig, J. Hombach, 2011, Vaccine.

Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine.

J. Farrar, A. Wilder-Smith, J. Hombach, 2016, The Journal of infectious diseases.

Assessing the Potential of a Candidate Dengue Vaccine with Mathematical Modeling

Mario Recker, Jan Medlock, Pejman Rohani, 2012, PLoS neglected tropical diseases.

Status of vaccine research and development of vaccines for dengue.

J. Hombach, A. Durbin, K. Vannice, 2016, Vaccine.

A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells

Hans Hengartner, H. Rammensee, R. Zinkernagel, 1998, European journal of immunology.

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.

Eva Harris, Marco Cavaleri, A. Barrett, 2018, Vaccine.

A global pandemic influenza vaccine action plan.

Keiji Fukuda, Marie Paule Kieny, R. Karron, 2006, Vaccine.

Models of the impact of dengue vaccines: a review of current research and potential approaches.

Michael A. Johansson, Derek A. T. Cummings, D. Cummings, 2011, Vaccine.